RxDoctor Payments Data

Lisa Asfahani

Physician Assistant · Riverside, CANPI 1902175623

Payments from drug & device makers

$24,582in general payments, 2019–2025

Across 723 payments — averaging $34.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$12K
  • Amgen$2K
  • Johnson & Johnson$2K
  • UCB, Inc.$2K
  • Mallinckrodt Hospital Products Inc.$1K
  • GSK$1K
  • plus $4K from 22 others

What the payments were for

  • Consulting fees$1,1255%
  • Speaking & faculty fees$6,30026%
  • Travel & lodging$2,67411%
  • Food & beverage$14,27058%
  • Education$2131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,582 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib49$345,559
Humira(Cf) PenAdalimumab33$267,956
ProliaDenosumab59$100,706
Enbrel SureclickEtanercept11$84,376
Xeljanz XrTofacitinib Citrate14$77,705
Teriparatide20$65,058
Actemra ActpenTocilizumab14$60,263
BenlystaBelimumab20$48,835
Hydroxychloroquine Sulfate379$18,344
Cevimeline Hcl26$5,973
MethotrexateMethotrexate Sodium227$5,562
Zoledronic AcidZoledronic Acid/Mannitol-Water19$3,801
Colchicine37$3,687
Mycophenolate Mofetil29$2,595
Pilocarpine Hcl17$1,762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$12,500$345,55949 claims
AmgenProlia$2,157$100,70659 claims
Alvogen IncTeriparatide$115$65,05820 claims
GSKBenlysta$1,156$48,83520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →